butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate

Modify Date: 2024-03-26 14:58:34

butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate Structure
butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate structure
Common Name butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate
CAS Number 55687-47-3 Molecular Weight 360.40800
Density 1.22g/cm3 Boiling Point 612.8ºC at 760 mmHg
Molecular Formula C18H24N4O4 Melting Point N/A
MSDS N/A Flash Point 324.4ºC

 Names

Name butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate

 Chemical & Physical Properties

Density 1.22g/cm3
Boiling Point 612.8ºC at 760 mmHg
Molecular Formula C18H24N4O4
Molecular Weight 360.40800
Flash Point 324.4ºC
Exact Mass 360.18000
PSA 124.04000
LogP 2.06610
Index of Refraction 1.587

 Safety Information

HS Code 2933599090

 Synthetic Route

~62%

butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate Structure

butyl 4-[(2,4-d...

CAS#:55687-47-3

Literature: Kompis; Then; Boehni; et al. European Journal of Medicinal Chemistry, 1980 , vol. 15, # 1 p. 17 - 22

~%

butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate Structure

butyl 4-[(2,4-d...

CAS#:55687-47-3

Literature: Hoffmann-La Roche Inc. Patent: US3931181 A1, 1976 ;

~%

butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate Structure

butyl 4-[(2,4-d...

CAS#:55687-47-3

Literature: Kompis; Then; Boehni; et al. European Journal of Medicinal Chemistry, 1980 , vol. 15, # 1 p. 17 - 22

~%

butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate Structure

butyl 4-[(2,4-d...

CAS#:55687-47-3

Literature: Kompis; Then; Boehni; et al. European Journal of Medicinal Chemistry, 1980 , vol. 15, # 1 p. 17 - 22

~%

butyl 4-[(2,4-diaminopyrimidin-5-yl)methyl]-2,6-dimethoxybenzoate Structure

butyl 4-[(2,4-d...

CAS#:55687-47-3

Literature: Kompis; Then; Boehni; et al. European Journal of Medicinal Chemistry, 1980 , vol. 15, # 1 p. 17 - 22

 Customs

HS Code 2933599090
Summary 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%